Table of Content
1 Natural Killer Cell Therapies Market Introduction and Overview
1.1 Natural Killer Cell Therapies Introduction
1.2 Research Purposes
1.3 Report Timeline
1.4 Market Size Analysis by Types
1.5 Market Size Analysis by Applications
1.6 Market Size Analysis by Regions
2 Global Market Growth Trends Analysis
2.1 Global Natural Killer Cell Therapies Market Size & Forecast (2017-2028)
2.2 Natural Killer Cell Therapies Growth Trends Analysis by Regions
2.2.1 Natural Killer Cell Therapies Market Size by Regions: 2017 VS 2021 VS 2027
2.2.2 Natural Killer Cell Therapies Historic Market Share by Regions (2017-2022)
2.2.3 Natural Killer Cell Therapies Forecasted Market Size by Regions (2023-2028)
3 Global Natural Killer Cell Therapies Historical and Forecast Market Analysis by Type
3.1 Global Natural Killer Cell Therapies Revenue and Market Share by Type
3.2 Global Natural Killer Cell Therapies Market Forecast by Type (2023-2028)
4 Global Natural Killer Cell Therapies Historical and Forecast Market Analysis by Applications
4.1 Global Natural Killer Cell Therapies Revenue Market Share by Application (2017-2022)
4.2 Natural Killer Cell Therapies Market Forecast by Application (2023-2028)
5 North America Natural Killer Cell Therapies Market analysis
5.1 North America Natural Killer Cell Therapies Revenue by Type (2017-2028)
5.2 North America Natural Killer Cell Therapies Revenue by Application (2017-2028)
5.3 North America Natural Killer Cell Therapies Revenue and Market Share by Countries
5.3.1 North America Natural Killer Cell Therapies Revenue by Country (2017-2028)
5.3.2 United States Natural Killer Cell Therapies Revenue and Growth (2017-2028)
5.3.3 Canada Natural Killer Cell Therapies Revenue and Growth (2017-2028)
5.3.5 Mexico Natural Killer Cell Therapies Revenue and Growth (2017-2028)
6 Europe Natural Killer Cell Therapies Market analysis
6.1 Europe Natural Killer Cell Therapies Revenue by Type (2017-2028)
6.2 Europe Natural Killer Cell Therapies Revenue by Application (2017-2028)
6.3 Europe Natural Killer Cell Therapies Revenue and Market Share by Countries
6.3.1 Europe Natural Killer Cell Therapies Revenue by Country (2017-2028)
6.3.2 Germany Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
6.3.3 France Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
6.3.4 United Kingdom Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
6.3.5 Russia Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
6.3.6 Italy Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
7 Asia-Pacific Natural Killer Cell Therapies Market analysis
7.1 Asia-Pacific Natural Killer Cell Therapies Revenue by Type (2017-2028)
7.2 Asia-Pacific Natural Killer Cell Therapies Revenue by Application (2017-2028)
7.3 Asia-Pacific Natural Killer Cell Therapies Revenue and Market Share by Countries
7.3.1 Asia-Pacific Natural Killer Cell Therapies Revenue by Country (2017-2028)
7.3.2 China Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
7.3.3 Japan Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
7.3.4 South Korea Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
7.3.5 India Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
7.3.6 Southeast Asia Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
7.3.7 Australia Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
8 Latin America Natural Killer Cell Therapies Market analysis
8.1 Latin America Natural Killer Cell Therapies Revenue by Type (2017-2028)
8.2 Latin America Natural Killer Cell Therapies Revenue by Application (2017-2028)
8.3 Latin America Natural Killer Cell Therapies Revenue and Market Share by Countries
8.3.1 Latin America Natural Killer Cell Therapies Revenue by Country (2017-2028)
8.3.2 Brazil Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
8.3.3 Argentina Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
9 Middle East & Africa Natural Killer Cell Therapies Market analysis
9.1 Middle East & Africa Natural Killer Cell Therapies Revenue by Type (2017-2028)
9.2 Middle East & Africa Natural Killer Cell Therapies Revenue by Application (2017-2028)
9.3 Middle East & Africa Natural Killer Cell Therapies Revenue and Market Share by Countries
9.3.1 Middle East & Africa Natural Killer Cell Therapies Revenue by Country (2017-2028)
9.3.2 Turkey Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
9.3.3 Saudi Arabia Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
9.3.4 UAE Natural Killer Cell Therapies Market Size and Forecast (2017-2028)
10 Natural Killer Cell Therapies Industry Dynamic Analysis
10.1 Natural Killer Cell Therapies Market Trends Analysis
10.2 Natural Killer Cell Therapies Market Drivers Analysis
10.3 Natural Killer Cell Therapies Market Challenges Analysis
10.4 Natural Killer Cell Therapies Market Restraints Analysis
10.5 Natural Killer Cell Therapies Industry Mergers & Acquisitions
10.6 Natural Killer Cell Therapies Industry New Entrants and Expansion Plans
11 Key Players Analysis
11.1 Global Natural Killer Cell Therapies Revenue and Market Share Analysis by Key Players
11.2 Global Natural Killer Cell Therapies Market Concentration Rate Analysis
11.2.1 Top 3 Natural Killer Cell Therapies Key Players Market Share
11.2.2 Top 6 Natural Killer Cell Therapies Key Players Market Share

11.3 Celgene Corporation
11.3.1 Business Overview
11.3.2 Natural Killer Cell Therapies Major Business
11.3.3 Celgene Corporation Product and Service Introduction
11.3.4 Celgene Corporation Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.3.5 Recent Developments and Future Plans
11.4 Ziopharm Oncology Inc.
11.4.1 Business Overview
11.4.2 Natural Killer Cell Therapies Major Business
11.4.3 Ziopharm Oncology Inc. Product and Service Introduction
11.4.4 Ziopharm Oncology Inc. Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.4.5 Recent Developments and Future Plans
11.5 Fortress Biotech
11.5.1 Business Overview
11.5.2 Natural Killer Cell Therapies Major Business
11.5.3 Fortress Biotech Product and Service Introduction
11.5.4 Fortress Biotech Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.5.5 Recent Developments and Future Plans
11.6 Nkarta Therapeutics, Inc.
11.6.1 Business Overview
11.6.2 Natural Killer Cell Therapies Major Business
11.6.3 Nkarta Therapeutics, Inc. Product and Service Introduction
11.6.4 Nkarta Therapeutics, Inc. Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.6.5 Recent Developments and Future Plans
11.7 Fate Therapeutics
11.7.1 Business Overview
11.7.2 Natural Killer Cell Therapies Major Business
11.7.3 Fate Therapeutics Product and Service Introduction
11.7.4 Fate Therapeutics Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.7.5 Recent Developments and Future Plans
11.8 Affimed N.V.
11.8.1 Business Overview
11.8.2 Natural Killer Cell Therapies Major Business
11.8.3 Affimed N.V. Product and Service Introduction
11.8.4 Affimed N.V. Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.8.5 Recent Developments and Future Plans
11.9 NKTTherapeutics Inc.
11.9.1 Business Overview
11.9.2 Natural Killer Cell Therapies Major Business
11.9.3 NKTTherapeutics Inc. Product and Service Introduction
11.9.4 NKTTherapeutics Inc. Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.9.5 Recent Developments and Future Plans
11.10 Nantkwest Inc
11.10.1 Business Overview
11.10.2 Natural Killer Cell Therapies Major Business
11.10.3 Nantkwest Inc Product and Service Introduction
11.10.4 Nantkwest Inc Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.10.5 Recent Developments and Future Plans
11.11 Glycostem Therapeutics BV
11.11.1 Business Overview
11.11.2 Natural Killer Cell Therapies Major Business
11.11.3 Glycostem Therapeutics BV Product and Service Introduction
11.11.4 Glycostem Therapeutics BV Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.11.5 Recent Developments and Future Plans
11.12 Innate Pharma S.A.
11.12.1 Business Overview
11.12.2 Natural Killer Cell Therapies Major Business
11.12.3 Innate Pharma S.A. Product and Service Introduction
11.12.4 Innate Pharma S.A. Natural Killer Cell Therapies Revenue, Gross Margin and Market Share
11.12.5 Recent Developments and Future Plans
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.2.3 Legal Disclaimer